Form Health vs Amgen

Side-by-side comparison of AI visibility scores, market position, and capabilities

Amgen leads in AI visibility (88 vs 36)
Form Health logo

Form Health

EmergingHealthTech

Virtual Weight Management

Virtual obesity medicine practice with board-certified physicians, dietitians, and coaches; treats obesity as a chronic disease using GLP-1 medications with individualized behavioral plans.

AI VisibilityBeta
Overall Score
D36
Category Rank
#530 of 596
AI Consensus
72%
Trend
stable
Per Platform
ChatGPT
41
Perplexity
33
Gemini
38

About

Form Health is a virtual obesity medicine practice that delivers medically supervised weight loss care through a team-based model pairing board-certified obesity medicine physicians with registered dietitians and health coaches, all accessible through a telehealth platform. The practice treats obesity as a complex chronic disease and develops individualized treatment plans that may include anti-obesity medications — including GLP-1 receptor agonists like semaglutide and tirzepatide — alongside nutritional counseling, behavioral health support, and physical activity guidance based on each patient's medical history, comorbidities, and treatment goals. This multidisciplinary approach mirrors the clinical model of a hospital-based obesity medicine program delivered through a scalable virtual format.

Full profile
Amgen logo

Amgen

LeaderHealthcare Tech

AI Drug Discovery

Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.

AI VisibilityBeta
Overall Score
A88
Category Rank
#3 of 596
AI Consensus
78%
Trend
stable
Per Platform
ChatGPT
83
Perplexity
87
Gemini
85

About

Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.

Full profile

AI Visibility Head-to-Head

36
Overall Score
88
#530
Category Rank
#3
72
AI Consensus
78
stable
Trend
stable
41
ChatGPT
83
33
Perplexity
87
38
Gemini
85
31
Claude
90
41
Grok
92

Key Details

Category
Virtual Weight Management
AI Drug Discovery
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Form Health
Virtual Weight Management
Only Amgen
AI Drug Discovery

Integrations

Amgen is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.